High purity Selank is a synthetic heptapeptide research compound modeled after the endogenous immunomodulatory sequence tuftsin, engineered with a C-terminal tripeptide extension to increase enzymatic resistance. PX1 Research supplies laboratory-grade Selank manufactured in ISO 17025-accredited, GMP-compliant facilities within the USA, backed by lot-specific analytical verification.
High purity Selank is a synthetic heptapeptide research compound modeled after the endogenous immunomodulatory sequence tuftsin, engineered with a C-terminal tripeptide extension to increase enzymatic resistance. PX1 Research supplies laboratory-grade Selank manufactured in ISO 17025-accredited, GMP-compliant facilities within the USA, backed by lot-specific analytical verification.
High purity Selank is a synthetic heptapeptide (sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro) research compound derived from the naturally occurring tetrapeptide tuftsin. By appending a Pro-Gly-Pro tripeptide sequence to the C-terminus, the molecule exhibits enhanced stability against peripheral peptidases. For in vitro and preclinical research, high purity Selank (>98% purity confirmed by RP-HPLC and ESI-MS) serves as a refined reagent for investigating GABAergic transmission, neurotrophic signal transduction, and peptidergic metabolic pathways without batch-to-batch variation or chemical artifact contamination.
Selank is structurally categorized as a regulatory synthetic peptide. Its parent sequence, tuftsin (Thr-Lys-Pro-Arg), represents a naturally occurring fragment of the human IgG heavy chain known to interact with immune cellular receptors. The addition of the Pro-Gly-Pro sequence prevents rapid cleavage by carboxypeptidases and endopeptidases, significantly extending the terminal elimination half-life in aqueous assay systems.
In chemical assays, high purity Selank presents as a lyophilized white powder with a molecular weight of approximately 751.9 g/mol. Achieving high purity during solid-phase peptide synthesis (SPPS) requires rigorous control over coupling efficiency, amino acid protection strategies, and post-cleavage purification protocols. Truncated sequences or incomplete deprotection products can interfere with receptor binding studies; thus, analytical verification is critical prior to experimental use.
In animal models and cell-based assays, Selank has been studied primarily for its influence on central neurotransmitter systems and gene expression profiles. Preclinical literature demonstrates that Selank modulates GABAergic signaling non-competitively, altering the affinity of allosteric sites on the GABA-A receptor complex without directly displacing primary agonists. Researchers examining neurochemical pathways utilize high purity Selank to map secondary messenger cascades associated with inhibitory neurotransmission.
In addition to GABAergic pathways, in vitro transcriptomic studies indicate that Selank upregulates mRNA expression of Brain-Derived Neurotrophic Factor (BDNF) and its primary tyrosine kinase receptor, TrkB, within hippocampal neuronal cultures. Animal studies further highlight Selank's role in inhibiting enkephalin-degrading enzymes (such as neutral endopeptidase and aminopeptidase N), thereby prolonging the endogenous activity of native opioid peptides. To review broader analytical evaluations on comparative neuro-active analogs, explore our Selank and Semax research review or consult our comprehensive research hub.
When designing neurochemical or comparative signaling protocols, laboratory investigators frequently contrast Selank with other synthetic regulatory peptides derived from endogenous physiological sequences. While Selank is derived from the immunomodulatory peptide tuftsin, its primary comparative compound, Semax, is a heptapeptide fragment derived from adrenocorticotropic hormone (ACTH 4-10) with an identical Pro-Gly-Pro C-terminal stabilizing motif.
Preclinical evaluations indicate distinct mechanism pathways between these molecules: Selank exhibits pronounced interactions with GABA-A receptor modulation and enkephalinase inhibition, whereas Semax primarily influences melanocortinergic receptors and brain-derived neurotrophic cascades. Furthermore, comparing these stabilized analogs against the unmodified precursor Tuftsin illustrates how C-terminal modifications dramatically extend peptide half-life in biological media. Researchers evaluating multi-target signaling pathways can access our full catalog via all research peptides to select exact reference standards.
High purity Selank intended for rigorous laboratory evaluation must meet strict chemical criteria. Impurities originating from synthesis—such as deletion peptides, racemized amino acids, or residual cleavage reagents like trifluoroacetic acid (TFA)—can introduce confounding variables in bioassays. PX1 Research enforces a baseline requirement of >98% purity across all peptide production batches.
Purity is quantitatively determined using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC). The resulting chromatogram must exhibit a distinct single peak corresponding to the target sequence, with total integrated area under secondary impurity peaks remaining below 2.0%. To confirm molecular identity, Electrospray Ionization Mass Spectrometry (ESI-MS) measures the mass-to-charge ratio (m/z), confirming that the observed molecular mass matches the theoretical mass of Selank precisely.
For cell culture assays, primary neuronal preparations, and baseline biochemical research, bacterial endotoxins (lipopolysaccharides, or LPS) present a serious contamination threat. Biological endotoxins stimulate Toll-like receptor 4 (TLR4), provoking unintended inflammatory cytokine cascades (such as IL-1β, IL-6, and TNF-α) that invalidate experimental measurements.
PX1 ResearchSubjects every lot of high purity Selank to quantitative Limulus Amebocyte Lysate (LAL) testing. We enforce strict endotoxin limits (<0.5 EU/mg), ensuring that observed cellular responses are directly attributable to the peptide compound rather than pyrogenic contaminants. Laboratories procuring materials for sensitive in vitro systems can verify these safety metrics directly on the batch certificate of analysis.
Selank is supplied as a sterile, lyophilized cake or powder designed for reconstitution in standard laboratory diluents. Due to its hydrophilic amino acid composition, high purity Selank dissolves readily in aqueous solvents. For aseptic cellular assays or non-clinical in vitro applications, sterile bacteriostatic water (0.9% benzyl alcohol) or sterile phosphate-buffered saline (PBS, pH 7.4) is typically recommended.
When reconstituting, researchers should introduce the diluent slowly along the glass inner wall of the vial to minimize shear stress and foam formation. Gentle swirling is advised; vigorous vortexing or mechanical agitation can disrupt secondary conformational stability. Once reconstituted, solutions should be aliquoted into single-use polypropylene microtubes to avoid repeated freeze-thaw cycles, which degrade peptide integrity over time.
Lyophilized Selank retains chemical stability for extended durations when stored under controlled environmental conditions. Unopened vials should be maintained at -20°C or -80°C in a desiccated container protected from direct light exposure. Under these conditions, the peptide maintains structural integrity for up to 24 months without significant hydrolysis or oxidation.
Following reconstitution, liquid aliquots should be stored at 2°C to 8°C for short-term experimentation (not exceeding 7 to 14 days) or frozen at -20°C for longer intervals. Exposure to elevated temperatures, ambient light, or basic pH environments accelerates deamidation and peptide chain cleavage. Research teams establishing standardized laboratory procedures can consult our guide on wholesale peptide storage protocols for enterprise lab management.
To maintain absolute compliance and reproducibility across scientific investigations, researchers must verify that their supplier provides independent, lot-specific testing. PX1 Research manufactures all compounds in ISO 17025-accredited and cGMP-compliant facilities located exclusively in the United States. Every production run undergoes independent verification by third-party analytical laboratories.
A complete Certificate of Analysis (COA) accompanies every lot of Selank. The COA explicitly details: (1) RP-HPLC chromatograms showing exact purity percentages, (2) ESI-MS spectrum confirming correct molecular weight, (3) LAL endotoxin quantification, and (4) residual solvent analysis. Transparency in batch testing guarantees that researchers receive non-degraded, unadulterated chemical reagents.
Timely delivery and supply chain integrity are vital for maintaining research timelines. PX1 Research operates dual fulfillment hubs in California and Arizona to support rapid domestic dispatch. Orders placed Monday through Friday prior to the daily cutoff time ship same-day via expedited courier services, minimizing transit times and environmental exposure.
Every vial dispatched features unique lot-number tracking linked directly to its manufacturing records and third-party analytical documentation. This complete chain of custody ensures full traceability from synthesis through laboratory receipt. Institutional procurement departments seeking specialized supply arrangements can learn more via our dedicated wholesale portal.
What is high purity Selank defined as in research settings?
High purity Selank refers to synthetic Thr-Lys-Pro-Arg-Pro-Gly-Pro sequence verified to possess >98% chemical purity via RP-HPLC and ESI-MS, free of significant deletion sequences, residual TFA, or endotoxins for strictly non-human laboratory research.
How is the purity of high purity Selank analytically verified?
Purity is quantified using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to measure peak area fractions, combined with Electrospray Ionization Mass Spectrometry (ESI-MS) to confirm exact molecular mass (751.9 g/mol).
What are the recommended storage temperature parameters for lyophilized Selank?
Lyophilized Selank should be stored at -20°C or -80°C in a dry, dark environment. Under these conditions, the peptide remains stable for up to 24 months.
How should high purity Selank be reconstituted for in vitro assays?
Aseptically add sterile bacteriostatic water or PBS along the inner wall of the vial. Gently swirl until fully dissolved; avoid high-speed vortexing to prevent physical denaturation.
What is the primary mechanical difference between Selank and Semax in preclinical literature?
Preclinical studies show Selank primarily modulates GABAergic systems and enkephalinase degradation, whereas Semax influences melanocortinergic signaling and ACTH-related neurotrophic expression.
What endotoxin threshold does PX1 Research guarantee for Selank?
PX1 Research enforces an endotoxin limit of <0.5 EU/mg across all peptide lots, confirmed via quantitative Limulus Amebocyte Lysate (LAL) testing.
Is high purity Selank suitable for human consumption or therapeutic use?
No. High purity Selank provided by PX1 Research is strictly designated for laboratory research use only and must not be administered to humans or animals for clinical or therapeutic purposes.
Where are PX1 Research peptides manufactured and tested?
All PX1 Research compounds are synthesized in USA-based, ISO 17025-accredited and cGMP-compliant facilities, with batch verification completed by independent third-party testing labs.
How can I obtain the Certificate of Analysis (COA) for my specific lot of Selank?
Certificates of Analysis featuring RP-HPLC chromatograms and mass spectra are available on the PX1 Research website by matching the lot number printed on the product vial.
What are the domestic fulfillment and shipping times for high purity Selank?
Orders placed Monday through Friday before the cutoff time ship same-day from PX1 Research fulfillment centers in California and Arizona via priority courier services.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.